News

August 4, 2017August 18, 2017

Takeda and Marvel Issue Final Chapters of IBD Superheroes Graphic Novel

Crohn's Disease, News

Takeda Pharmaceutical and Marvel Custom Solutions have released two new chapters of IBD Unmasked, a graphic novel designed to raise awareness of the unrecognized superheroes of the global inflammatory bowel disease ... Read more

August 3, 2017August 18, 2017

University of Arizona Obtains $1.9 Million U.S. Government Grant To Study Key Protein’s Role in Bowel Disease

Crohn's Disease, News

University of Arizona scientists have received a $1.9 million U.S. government grant to study how a protein helps maintain a healthy mix of gut bacteria, and how interfering with the ... Read more

August 2, 2017August 18, 2017

Phase 3 Trial of RHB-104 as Combination Therapy for Moderate to Severe Crohn’s Is on Track, Review Board Says

Crohn's Disease, News

An independent review board has confirmed the preliminary findings of a Phase 3 clinical trial showing that RHB-104 is a safe and effective combination treatment for Crohn’s disease. The Data ... Read more

August 1, 2017August 23, 2017

CrownBio Launches New Animal Models to Aid IBD, Rheumatoid Arthritis Research Efforts

Crohn's Disease, News

Crown Bioscience has introduced preclinical models of inflammatory bowel disease (IBD) and rheumatoid arthritis (RA) to help scientists study both disorders and test potential therapies before they can be given to ... Read more

July 31, 2017August 18, 2017

Kezar Raises $50M to Support Development of KZR-616 for Autoimmune Diseases

Crohn's Disease, News

Kezar Life Sciences raised $50 million in a financing round to support further clinical development of its lead drug candidate KZR-616 for the treatment of several autoimmune and inflammatory diseases, including ... Read more

July 28, 2017August 18, 2017

People Living in a Rural Area Less Likely to Develop Bowel Disease, Study Finds

Crohn's Disease, News

Living in a rural area decreases a person’s risk of developing inflammatory bowel disease, particularly for children and teenagers, a Canadian study reports. The findings are of particular interest to Canada ... Read more

July 26, 2017August 18, 2017

Renflexis, a Remicade Biosimilar, Launched in US to Treat Crohn’s and UC

Crohn's Disease, News

New drug Renflexis (infliximab-abda), a therapy for ulcerative colitis and Crohn’s disease, is being launched in the U.S., South Korea’s Samsung Bioepis recently announced. Renflexis is a biosimilar of the anti-inflammatory ... Read more

July 24, 2017August 18, 2017

Bowel Disease Clinical Trial Community to Educate Patients About the Process, Including Enrolling

Crohn's Disease, News

The Crohn’s & Colitis Foundation has created a Clinical Trial Community program to bring together patients, healthcare providers, research coordinators and trial investigators to facilitate bowel disease trial development and enrollment. Clinical ... Read more

July 21, 2017August 18, 2017

Cannabosides Show Positive Results as Potential Colitis Treatment in Preclinical Studies

News, Ulcerative colitis

A new class of ingestible cannabinoid prodrugs known as cannabosides developed to treat colitis have shown positive results in preclinical studies, Vitality Biopharma has announced. Cannabosides are a modification of a novel class ... Read more

July 20, 2017August 29, 2017

Food Additive Titanium Dioxide Can Exacerbate Bowel Disease, Study in Mice Suggests

Crohn's Disease, News

The food additive titanium dioxide, found in chewing gum and marshmallows, can exacerbate inflammatory bowel disease, a study of mice with colitis indicates. People with Crohn’s disease, ulcerative colitis and other bowel disorders should ... Read more